TNF and hereditary sensory and autonomic neuropathy: Jason Beattie and colleagues reported that among 26 patients receiving additional immunomodulators (tumor necrosis factor-alpha inhibitors and/or mycophenolate) for steroid-refractory CIP, 38% (10/26) achieved durable improvement (172).